Every MedTech sales rep has a story about the “sure thing” — the surgeon who promised to get it through the committee, then went silent for six months. He didn’t change his mind; he was outgunned by a procurement team armed with utilization data and a mandate to cut costs.
Clinical superiority is the price of entry, not the sale. The real sale happens when the clinician has to defend your value proposition in a room full of people who have never seen the inside of an OR. Red House calls the fix “Advocacy Enablement”: clinical evidence content that links outcomes to service-line profitability, a pivot from preference to necessity framed on hospital KPIs, and a committee preparation kit your champion can drop into a deck in five minutes.
